Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases

Journal of Gastrointestinal Surgery

Volumn 8, Issue 2, 2004, Pages 150-158

  Schüssler Fiorenza, Chris M ^a   Mahvi, David M ^a   Niederhuber, John ^a   Rikkers, Layton F ^a   Weber, Sharon M ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Colorectal hepatic metastases; PET scan

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; CANCER RISK; CANCER SIZE; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGING SYSTEM; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM;

EID: 1242328744     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.11.009     Document Type: Conference Paper

References (15)

1. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg. 230:1999;309-318.
2. Nordlinger B., Guiguet M., Vaillant J.C., Balladur P., Boudjema K., Bachellier P., Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 77:1996;1254-1262.
3. Fong Y., Saldinger P.F., Akhurst T., Macapinlac H., Yeung H., Finn R.D., Cohen A., Kemeny N., Blumgart L.H., Larson S.M. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg. 178:1999;282-287.
4. Strasberg S.M., Dehdashti F., Siegel B.A., Drebin J.A., Linehan D. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: A prospective database study. Ann Surg. 233:2001;293-299.
5. Huebner R.H., Park K.C., Shepherd J.E., Schwimmer J., Czernin J., Phelps M.E., Gambhir S.S. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med. 41:2000;1177-1189.
6. Jarnagin W.R., Conlon K., Bodniewicz J., Dougherty E., DeMatteo R.P., Blumgart L.H., Fong Y. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer. 91:2001;1121-1128.
7. Ruers T.J., Langenhoff B.S., Neeleman N., Jager G.J., Strijk S., Wobbes T., Corstens F.H., Oyen W.J. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study. J Clin Oncol. 20:2002;388-395.
8. Desai D.C., Zervos E.E., Arnold M.W., Burak W.E. Jr., Mantil J., Martin E.W. Jr. Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol. 10:2003;59-64.
9. Boykin K.N., Zibari G.B., Lilien D.L., McMillan R.W., Aultman D.F., McDonald J.C. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg. 65:1999;1183-1185.
10. Lai D.T., Fulham M., Stephen M.S., Chu K.M., Solomon M., Thompson J.F., Sheldon D.M., Storey D.W. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg. 131:1996;703-707.
11. Jarnagin W.R., Fong Y., Ky A., Schwartz L.H., Paty P.B., Cohen A.M., Blumgart L.H. Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease. J Am Coll Surg. 188:1999;33-42.
12. Hany T.F., Steinert H.C., Goerres G.W., Buck A., Von Schulthess G.K. PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results. Radiology. 225:2002;575-581.
13. D'Amico T.A., Wong T.Z., Harpole D.H., Brown S.D., Coleman R.E. Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. Ann Thorac Surg. 74:2002;160-163.
14. Petrowsky H., Gonen M., Jarnagin W., Lorenz M., DeMatteo R., Heinrich S., Encke A., Blumgart L., Fong Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann Surg. 235:2002;863-871.
15. Topal B., Flamen P., Aerts R., D'Hoore A., Filez L., Van Cutsem E., Mortelmans L., Penninckx F. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol. 27:2001;175-179.